Multiple newly identified loci associated with prostate cancer susceptibility

Prostate cancer is the most common cancer affecting males in developed countries. It shows consistent evidence of familial aggregation, but the causes of this aggregation are mostly unknown. To identify common alleles associated with prostate cancer risk, we conducted a genome-wide association study (GWAS) using blood DNA samples from 1,854 individuals with clinically detected prostate cancer diagnosed at ≤60 years or with a family history of disease, and 1,894 population-screened controls with a low prostate-specific antigen (PSA) concentration (<0.5 ng/ml). We analyzed these samples for 541,129 SNPs using the Illumina Infinium platform. Initial putative associations were confirmed using a further 3,268 cases and 3,366 controls. We identified seven loci associated with prostate cancer on chromosomes 3, 6, 7, 10, 11, 19 and X (P = 2.7 × 10−8 to P = 8.7 × 10−29). We confirmed previous reports of common loci associated with prostate cancer at 8q24 and 17q. Moreover, we found that three of the newly identified loci contain candidate susceptibility genes: MSMB, LMTK2 and KLK3.

[1]  R. Eeles,et al.  Genetic predisposition to prostate cancer. , 2016, British medical bulletin.

[2]  D. English,et al.  Smoking and prostate cancer: findings from an Australian case-control study. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. English,et al.  Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  L. D. Barnes,et al.  An Adjacent Pair of Human NUDT Genes on Chromosome X Are Preferentially Expressed in Testis and Encode Two New Isoforms of Diphosphoinositol Polyphosphate Phosphohydrolase* , 2002, The Journal of Biological Chemistry.

[5]  E. Bleecker,et al.  Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels. , 2003, Journal of the National Cancer Institute.

[6]  D. English,et al.  ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. , 2003, Journal of the National Cancer Institute.

[7]  B. Ponder,et al.  Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. , 2003, American journal of human genetics.

[8]  D. English,et al.  Body size and composition and prostate cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  R. Eeles,et al.  Unravelling the genetics of prostate cancer , 2004, American journal of medical genetics. Part C, Seminars in medical genetics.

[10]  Tadashi Yamamoto,et al.  Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[11]  D. Duggan,et al.  Recent developments in genomewide association scans: a workshop summary and review. , 2005, American journal of human genetics.

[12]  A. Gylfason,et al.  A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.

[13]  J. R. Reeves,et al.  Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy , 2006, Clinical Cancer Research.

[14]  D. English,et al.  Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA , 2006, Cancer Epidemiology Biomarkers & Prevention.

[15]  A. Whittemore,et al.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men , 2006, Proceedings of the National Academy of Sciences.

[16]  Hartwig Huland,et al.  Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum , 2006, International journal of cancer.

[17]  D. English,et al.  Circulating Steroid Hormones and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[18]  A. Whittemore,et al.  Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.

[19]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[20]  D. Gudbjartsson,et al.  Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes , 2007, Nature Genetics.

[21]  Andrew J Vickers,et al.  Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[23]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[24]  C. P. Morris,et al.  PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. , 2006, Carcinogenesis.

[25]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[26]  Hans Lilja,et al.  Circulating biomarkers for prostate cancer , 2007, World Journal of Urology.

[27]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[28]  D. Clayton,et al.  An R Package for Analysis of Whole-Genome Association Studies , 2007, Human Heredity.

[29]  J. Brooks.  Multiple newly identified loci associated with prostate cancer susceptibility , 2008 .

[30]  L. Shulman,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2008 .

[31]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.